High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: A study of 27 patients from a single centre

Annals of Oncology - Tập 9 Số 8 - Trang 865-869 - 1998
James M. Foran1, John Apostolidis2, D. Papamichael2, A. J. Norton3, B. Talin2, J. Amess4, Tim Lister2, A. Z. S. Rohatiner2
1ICRF Medical Oncology Unit, Department of Medical Oncology, St. Bartholomew's Hospital, London, UK
2ICRF Medical Oncology Unit, Department of Medical OncologyLondon, UK
3Department of Hislopathology, St. Bartholomew's HospitalLondon, UK
4Department of Haematology, St. Bartholomew's HospitalLondon, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Brill, 1925, Generalized giant lymph follicle hyperplasia of the lymph nodes and spleen, JAMA, 84, 668, 10.1001/jama.1925.02660350032008

Symmers, 1938, Giant follicular lymphadenopathy with or without splenomegaly, Arch Path, 26, 603

Gall, 1942, Malignant lymphoma: A clinicopathological survey of 618 cases, Am J Pathol, 18, 381

Horning, 1984, The natural history of initially untreated low-grade non-Hodgkin’s lymphomas, N Engl J Med, 311, 1471, 10.1056/NEJM198412063112303

Gallagher, 1986, Follicular lymphoma: Prognostic factors for response and survival, J Clin Oncol, 4, 1470, 10.1200/JCO.1986.4.10.1470

Harris, 1994, A revised European–American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group, Blood, 84, 1361, 10.1182/blood.V84.5.1361.1361

1982, National Cancer Institute sponsored study of classifications of non-Hodgkin’s lymphomas: Summary and description of a working formulation for clinical usage, Cancer, 49, 2112, 10.1002/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2

Brittinger, 1984, Clinical and prognostic relevance of the Kiel classification of non-Hodgkin’s lymphomas: Results of a prospective multicentre study by the Kiel lymphoma study group, Haematol Oncol, 2, 269, 10.1002/hon.2900020306

Bastion, 1991, Follicular lymphomas: Assessment of prognostic factors in 127 patients followed for 10 years, Ann Oncol, 2, 123, 10.1093/annonc/2.suppl_2.123

Garvin, 1983, An autopsy study of histologic progression in non-Hodgkin’s lymphomas, Cancer, 52, 393, 10.1002/1097-0142(19830801)52:3<393::AID-CNCR2820520302>3.0.CO;2-M

Cullen, 1979, Histological transformation of non-Hodgkin’s lymphoma, Cancer, 44, 645, 10.1002/1097-0142(197908)44:2<645::AID-CNCR2820440234>3.0.CO;2-Y

Armitage, 1981, Diffuse histiocytic lymphoma after histologic conversion: A poor prognostic variant, Cancer Treat Rep, 65, 413

Ostrow, 1981, Nodular poorly differentiated lymphocytic lymphoma: Changes in histology and survival, Cancer Treat Rep, 65, 929

Hubbard, 1982, Histologic progression in non-Hodgkin’s lymphoma, Blood, 59, 258, 10.1182/blood.V59.2.258.258

Acker, 1983, Histologic conversion in the non-Hodgkin’s lymphomas, J Clin Oncol, 1, 11, 10.1200/JCO.1983.1.1.11

Bastion, 1997, Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients, J Clin Oncol, 15, 1587, 10.1200/JCO.1997.15.4.1587

Philip, 1987, High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade or highgrade non-Hodgkin’s lymphoma, N Engl J Med, 316, 1493, 10.1056/NEJM198706113162401

Philip, 1995, Autologous bone marrow transplantation as compared to salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma, N Engl J Med, 333, 1540, 10.1056/NEJM199512073332305

Williams, 1996, Chemosensitive transformed follicular non-Hodgkin’s lymphoma is a firm indication for high-dose therapy and autologous stem cell transplantation. A study from the EBMT registry, (Proc Am Soc Hematol) Blood, 88, 685a

Whelan, 1992, Etoposide in combination with intermediate dose cytosine arabinoside given with the intention of further myeloablative therapy for the treatment of refractory or recurrent hematological malignancy, Hematol Oncol, 10, 87, 10.1002/hon.2900100204

Dhaliwal, 1993, Combination chemotherapy for intermediate and high-grade non-Hodgkin’s lymphoma, Br J Cancer, 68, 767, 10.1038/bjc.1993.425

Rohatiner, 1994, Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma, J Clin Oncol, 12, 1177, 10.1200/JCO.1994.12.6.1177

Pigaditou, 1995, Myelo-ablative therapy with peripheral blood progenitor cell support in patients with haematological malignancy, Ann Oncol, 6, 53, 10.1093/oxfordjournals.annonc.a059042

Kaplan, 1958, Non-parametric estimation from incomplete observation, Am Stats Assoc J, 53, 457, 10.1080/01621459.1958.10501452

Schouten, 1989, Autologous bone marrow transplantation in follicular non-Hodgkin’s lymphoma before and after histologic conversion, Blood, 74, 2579, 10.1182/blood.V74.7.2579.2579

Freedman, 1991, Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin’s lymphoma, Blood, 77, 2524, 10.1182/blood.V77.11.2524.2524

Bastion, 1995, Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma, Blood, 86, 3257, 10.1182/blood.V86.8.3257.3257

Yuen, 1995, Long-term survival after histological transformation of low-grade follicular lymphoma, J Clin Oncol, 13, 1726, 10.1200/JCO.1995.13.7.1726